These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15694700)

  • 1. Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymes.
    Wiseman A
    Med Hypotheses; 2005; 64(4):802-5. PubMed ID: 15694700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms that regulate production of reactive oxygen species by cytochrome P450.
    Zangar RC; Davydov DR; Verma S
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):316-31. PubMed ID: 15364547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-induced reperfusion-injury is caused by ROS: Amelioration is possible by recombinant-DNA antioxidant enzymes and mimics in selected tissues.
    Wiseman A
    Med Hypotheses; 2006; 66(2):329-31. PubMed ID: 16213102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen-receptors (ER) are likely to be promiscuous: wider role for oestrogens and mimics.
    Wiseman A
    Med Hypotheses; 2005; 65(4):760-5. PubMed ID: 15961252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 polymorphism--molecular, metabolic and pharmacogenetic aspects. I. Mechanisms of activity of cytochrome P450 monooxygenases.
    Pachecka J; Tomaszewski P; Kubiak-Tomaszewska G
    Acta Pol Pharm; 2008; 65(3):303-6. PubMed ID: 18646549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
    Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
    Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
    Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450-mediated metabolism of estrogens and its regulation in human.
    Tsuchiya Y; Nakajima M; Yokoi T
    Cancer Lett; 2005 Sep; 227(2):115-24. PubMed ID: 16112414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.
    Godin SJ; Crow JA; Scollon EJ; Hughes MF; DeVito MJ; Ross MK
    Drug Metab Dispos; 2007 Sep; 35(9):1664-71. PubMed ID: 17576809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
    Leoni C; Buratti FM; Testai E
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 enzymes and the heart.
    Chaudhary KR; Batchu SN; Seubert JM
    IUBMB Life; 2009 Oct; 61(10):954-60. PubMed ID: 19787709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnological synthesis of drug metabolites using human cytochrome P450 isozymes heterologously expressed in fission yeast.
    Peters FT; Bureik M; Maurer HH
    Bioanalysis; 2009 Jul; 1(4):821-30. PubMed ID: 21083140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.